Table 1. Leaders in the number of public-private partnerships. The European Commission and Cancer Research UK took the top positions with respect to the number of disclosed public-private partnerships (PPPs) in 2013. AstraZeneca took the top spot on the company side, and Johnson & Johnson took the second spot. Excludes deals that only involve IP transfer.

Source: BioCentury Archives

Institution

Number of PPPs

European Commission

21

Cancer Research UK

10

Agency for Science, Technology and Research (A*STAR)

8

Harvard University

8

University of California, San Francisco; University of California, Los Angeles; University of California, Davis

8

Company

Number of PPPs

AstraZeneca plc (LSE:AZN; NYSE:AZN)

14

Johnson & Johnson (NYSE:JNJ)

11

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK)

10

Pfizer Inc. (NYSE:PFE)

9

Sanofi (Euronext:SAN; NYSE:SNY)

9